Clinical Trial Update: Treating Drug-Resistant Childhood Schizophrenia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial addressing drug-resistant childhood schizophrenia has completed. The sponsor is Northwell Health.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: Northwell Health | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED